Bay of Plenty-based medicinal cannabis firm Eqalis raises $6m
Company predicts it will be ‘cashflow positive’ by middle of 2023.
Eqalis strategy and operations leader David Macaskill.
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Local medicinal cannabis firm Eqalis Pharmaceuticals has received great support during its latest capital raise.
The company raised $6 million from existing and new investors and was now working with its shareholders to approve up to $2m in oversubscriptions.
It was the company’s sixth funding
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Monthly Premium Online Subscription
NZ$49.95 / monthly
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Yearly Premium Online Subscription
NZ$499.00 / yearly
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly
credit card debit
Premium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly
credit card debit
Premium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly
credit card debit
Premium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly
credit card debit
Yearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Individual
Group membership
NBR Marketplace
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
